Effects of L-Carnitine Supplementation on Respiratory Distress Syndrome

Effects of Adding L-Carnitine With Dexamethasone on Respiratory Distress Syndrome Development in Preterm Infants

Status

Withdrawn

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03630367

Enrollment

Registered

2018-08-14

Start date

2018-10-03

Completion date

2020-10-31

Last updated

2021-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature Birth

Brief summary

The aim of the present study was to investigate the efficacy of L-carnitine therapy on the occurrence and prognosis of respiratory distress syndrome

Interventions

DRUGDexamethasone

Intramuscular injection 8 mg

DRUGL-Carnitine 1G/5mL Injection

slow intravenous injection

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

FEMALE

Healthy volunteers

Inclusion criteria

* Pregnant women between 30-37 weeks * singleton pregnancy

Exclusion criteria

* congenital malformed fetus * Extreme premature

Design outcomes

Primary

Measure	Time frame	Description
the mean difference in the Apgar score after birth	1 minute	Assessment of fetal general condition

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026